Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LepVax (LEP-F1 + GLA-SE) in healthy adults
NCT03302897Phase 1Completed
- Sponsor
- Access to Advanced Health Institute
- Start
- Oct 2017
- Primary completion
- Mar 2019
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of liposomal fenofibrate in leprosy (HD), sponsored by Access to Advanced Health Institute. Started Oct 2017; status: completed.
02
Drugs
liposomal fenofibrate
03
Conditions
leprosy (HD)
Beyond the preview
Go deeper on NCT03302897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03302897.